Form D · Other Health Care
Nurture Genomics, Inc.
Cambridge, MA · CIK 0001949258
Offering snapshot reported Sep 9, 2025 · SEC filing
- Reported sold
- $4.34M Offering amount: $6M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Sep 23, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2025 | Amendment | $4,335,000 | No comparison | 40 | SEC filing |
| Aug 8, 2023 | Amendment | $1,705,000 | $1,350,000vs Oct 5, 2022 | 20 | SEC filing |
| Oct 5, 2022 | Initial | $355,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-460778
Source: Form D, filed Sep 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steffanie Bristol | Executive |
| David Feinberg | Executive |
| Robert C Green | Director, Executive |
| Hans Keil | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Cambridge Innovation Center, 1 Broadway
Cambridge, MA, 02142
Cambridge, MA, 02142